ThePharmyard Tightening Regulations and Raising Standards in UK Marketing Communications: the new ABPI Code of Practice (2008) explained)
Pay-as-you-go medical and pharmaceutical industry information About Us | Contact Us | Terms
ThePharmYard provides instant access to a unique database of specialist information which is particularly relevant to individuals working within the medical and pharmaceutical industries around the world. Titles from a diverse range of independent publishers are available to purchase in electronic document format for immediate access.

Number of publications currently listed: 1658

LATEST PUBLICATIONS - JULY 2008:

Generics Threats And Opportunities: Mounting an Effective Defense Strategy - published by Eularis

The report, by Dr Andree Bates of Eularis, analyzes the most effective legal, reformulation and marketing strategies to counteract the generic threat and details the benefits of an integrated brand defense strategy.

Tightening Regulations and Raising Standards in UK Marketing Communications: the new ABPI Code of Practice (2008) explained - published by KeywordPharma

Steven Gray takes an in-depth look at the new 2008 Code of Practice from the ABPI. The revisions it contains are largely but not only the direct requirements of the 2007 European Federation of Pharmaceutical Industries and Associations (EFPIA) Code.

Pharmaceutical Pricing and Distribution in Japan: The keys to success in the world’s second largest market - published by JustPharmaReports

Donald Macarthur explains why no serious multinational can afford to ignore Japan where it remains a tough and highly competitive market to crack, with the environment for developing and marketing medicines dominated by price.

Adalimumab in ankylosing spondylitis: an evidence-based review of its place in therapy - published by Core Medical Publishing

Abbott’s Humira (adalimumab) improves signs and symptoms, inflammation, and quality of life in patients with ankylosing spondylitis, and is cost effective when used according to current guidelines.

Paliperidone: the evidence of its therapeutic value in schizophrenia - published by Core Medical Publishing

Janssen's Invega (paliperidone) is a metabolite of risperidone that is effective in reducing symptoms of schizophrenia, and preventing relapse. However its cost effectiveness remains to be determined.

FEATURED PUBLICATION: The Journal of Generic Medicines is guided by its respected Editor Greg Perry (European Generic Medicines Association) and an international Editorial Board of leading practitioners and Association representatives from the generics industry. Journal of Generic Medicines is the major, international business journal written by and for expert analysis, briefings and legal updates on all aspects of business development, regulatory affairs, manufacturing and marketing affecting the generic pharmaceutical industry. Each quarterly issue publishes analyses, briefings and updates which are of direct relevance to practitioners and that meet the highest intellectual standards.

Recent titles include:

Pharmacists' views on generic medicines: A review of the literature - Published by Palgrave Macmillan in the Journal of Generic Medicines

The value of patent term extensions to the pharmaceutical industry in the USA - Published by Palgrave Macmillan in the Journal of Generic Medicines

How to make the most of IP due diligence in deals involving generics - Published by Palgrave Macmillan in the Journal of Generic Medicines

Pricing strategies of originator and generic medicines following patent expiry in Belgium - Published by Palgrave Macmillan in the Journal of Generic Medicines

Climate of change continues in Canada - Published by Palgrave Macmillan in the Journal of Generic Medicines

Impact of the Amended Indian Patent Act on the Indian pharmaceutical industry - Published by Palgrave Macmillan in the Journal of Generic Medicines

The market exclusivity period for new drugs in Japan: Overview of intellectual property protection and related regulations - Published by Palgrave Macmillan in the Journal of Generic Medicines

Competition aspects of pharmaceutical patent settlements and licences in Australia - Published by Palgrave Macmillan in the Journal of Generic Medicines

Rebate contracts: Risks and chances in the German generic market - Published by Palgrave Macmillan in the Journal of Generic Medicines

In pursuit of distinction: The method of the non-proprietary name - Published by Palgrave Macmillan in the Journal of Generic Medicines

PUBLICATIONS ARE AVAILABLE FROM THE FOLLOWING PUBLISHERS:

:: View our full list of titles from Bridgehead International

:: View our full list of titles from Chiltern International

:: View our full list of titles from Core Medical Publishing

:: View our full list of titles from CSF Medical Communications

:: View our full list of titles from CurrentPartnering

:: View our full list of titles from Dove Medical Press

:: View our full list of titles from Eularis

:: View our full list of titles from Euromed Communications

:: View our full list of titles from Garev Publishing International

:: View our full list of titles from JustPharmaReports

:: View our full list of titles from KeywordPharma

:: View our full list of titles from Merit International Publishing

:: View our full list of titles from the Medical Science Liaison Institute

:: View our full list of titles from the Palgrave Macmillan

:: View our full list of titles from Pelican Publications UK

:: View our full list of titles from Performance Management Coaching

:: View our full list of titles from Pharmalicensing

:: View our full list of titles from PharmaVentures

:: View our full list of titles from Remedica Publishing

:: View our full list of titles from Urch Publishing

:: View our full list of titles from VirSci Corporation

Affiliates | About Us | Contact Us | Terms

Copyright 2008
ThePharmYard is an initiative for the international medical and pharmaceutical industries from NetworkPharma Ltd.

We accept the following credit and debit cards: amex visa visa_delta visa_electron mastercard switch jcb solo